ACE and stroke disorder: A systematic review of ischemic stroke survivors on either ACE inhibitors or ARBs showed a modest reduction in risk for recurrent strokes [62] as a secondary prevention strategy, thus a larger sample size may be required to show benefit or otherwise of ACE-I and ARBs in primary prevention of stroke in SSA.